News
Is this tech company behind CEO's bid for 23andMe genetic data? How Anne Wojcicki's group still could snag 23andMe How Anne ...
There are a few clues about a mystery backer for Anne Wojcicki's bankruptcy bid for 23andMe, and they point toward a software ...
Me is teetering on the edge of bankruptcy and actively seeking a buyer. That buyer, unless explicitly restricted, could gain ...
Me has filed for Chapter 11 bankruptcy protection in the U.S., which means your genetic data is for sale, and you only have ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
The founder of 23andMe has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, ...
A key decision by the bankruptcy judge could help with protecting consumer data, write Diane Lourdes Dick and Anya Prince.
Missouri Attorney General Andrew Bailey is alerting consumers that 23andMe, Lemonaid Health, Telehealth and Pharmacy filed ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
As the EU enacts its landmark health data law, officials warn that public trust, not just infrastructure, will determine its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results